Getein Biotech, Inc (SHA:603387)
9.39
-0.04 (-0.42%)
Aug 14, 2026, 3:00 PM CST
Getein Biotech Market Cap
Getein Biotech has a market cap or net worth of 4.76 billion as of August 14, 2026. Its market cap has increased by 6.95% in one year.
Market Cap
4.76B
Enterprise Value
3.91B
Revenue
1.08B
Ranking
n/a
PE Ratio
20.38
Stock Price
9.39
ChartMarket Cap Chart
Since July 17, 2017, Getein Biotech's market cap has increased from 4.23B to 4.76B, an increase of 12.60%. That is a compound annual growth rate of 1.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 4.76B | 12.19% |
| Dec 31, 2025 | 4.24B | 1.45% |
| Dec 31, 2024 | 4.18B | -25.00% |
| Dec 29, 2023 | 5.58B | -12.00% |
| Dec 30, 2022 | 6.34B | -12.61% |
| Dec 31, 2021 | 7.25B | -18.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Sanyou Medical | 5.05B |
| Wuhan Huakang Century Clean Technology | 4.94B |
| Shenzhen Lifotronic Technology | 4.86B |
| Nanjing Vishee Medical Technology | 4.82B |
| Guangdong Biolight Meditech | 4.79B |
| Contec Medical Systems Co.,Ltd | 4.66B |
| Shanghai Kinetic Medical | 4.47B |
| Hangzhou AGS MedTech | 4.37B |